Sionna Therapeutics (SION) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for Sionna Therapeutics (SION).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||
Research And Development | 19M (+24.98%) | 15M (-5.42%) | 16M (+4.29%) | 15M (+12.51%) | 14M (-4.07%) | 14M (-42.03%) | 25M (+198.66%) | 8.23M (-19.47%) | 10M |
Selling General And Administrative | 11M (+26.07%) | 8.44M (+8.76%) | 7.76M (+19.02%) | 6.52M (+8.85%) | 5.99M (+54.38%) | 3.88M (+14.12%) | 3.40M (+11.11%) | 3.06M (+4.44%) | 2.93M |
Operating Expenses | 30M (+25.37%) | 24M (-0.84%) | 24M (+8.67%) | 22M (+11.44%) | 20M (+8.44%) | 18M (-35.20%) | 28M (+147.83%) | 11M (-14.14%) | 13M |
Depreciation And Amortization | 150K (-48.28%) | 290K (+190.00%) | 100K (0.00%) | 100K (-37.50%) | 160K (+60.00%) | 100K (-50.00%) | 200K (0.00%) | 200K (+17.65%) | 170K |
Operating Income | |||||||||
Operating Income | -29.60M (+25.37%) | -23.61M (-0.80%) | -23.80M (+8.63%) | -21.91M (+11.44%) | -19.66M (+8.44%) | -18.13M (-35.20%) | -27.98M (+147.83%) | -11.29M (-14.14%) | -13.15M |
Ebit | -29.60M (+25.37%) | -23.61M (-0.80%) | -23.80M (+8.63%) | -21.91M (+11.44%) | -19.66M (+8.44%) | -18.13M (-35.20%) | -27.98M (+147.83%) | -11.29M (-14.14%) | -13.15M |
EBITDA | -29.44M (+26.24%) | -23.32M (-1.60%) | -23.70M (+8.67%) | -21.81M (+11.85%) | -19.50M (+8.15%) | -18.03M (-35.10%) | -27.78M (+150.50%) | -11.09M (-14.56%) | -12.98M |
Other Income / Expenses | |||||||||
Interest Income | 2.82M (-11.04%) | 3.17M (-8.38%) | 3.46M (-5.72%) | 3.67M (+22.33%) | 3.00M (+41.51%) | 2.12M (-9.79%) | 2.35M (-8.56%) | 2.57M (+127.43%) | 1.13M |
Net Interest Income | 2.82M (-11.04%) | 3.17M (-8.38%) | 3.46M (-5.72%) | 3.67M (+22.33%) | 3.00M (+41.51%) | 2.12M (-9.79%) | 2.35M (-8.56%) | 2.57M (+127.43%) | 1.13M |
Other Non Operating Income | 2.82M (-79.43%) | 14M (+288.39%) | 3.53M (-8.07%) | 3.84M (+20.75%) | 3.18M (-64.15%) | 8.87M (+249.21%) | 2.54M (-7.30%) | 2.74M (+110.77%) | 1.30M |
Net Income | |||||||||
Net Income From Continuing Operations | -26.78M (+31.02%) | -20.44M (+0.79%) | -20.28M (+12.23%) | -18.07M (+9.65%) | -16.48M (+3.97%) | -15.85M (-37.70%) | -25.44M (+197.54%) | -8.55M (-27.85%) | -11.85M |
Net Income | -26.78M (+31.02%) | -20.44M (+0.79%) | -20.28M (+12.23%) | -18.07M (+9.65%) | -16.48M (+3.97%) | -15.85M (-37.70%) | -25.44M (+197.54%) | -8.55M (-27.85%) | -11.85M |
Comprehensive Income Net Of Tax | -27.40M (-63.52%) | -75.10M (+274.75%) | -20.04M (+10.17%) | -18.19M (+9.91%) | -16.55M (-73.01%) | -61.32M (+150.18%) | -24.51M (+181.72%) | -8.70M (-26.58%) | -11.85M |